Viewing Study NCT01988103


Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2026-02-21 @ 1:19 AM
Study NCT ID: NCT01988103
Status: COMPLETED
Last Update Posted: 2020-05-07
First Post: 2013-05-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
None Psoriatic Arthritis View
None Psoriasis Arthropatica View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis; Psoriatic Arthritis View